1-1 of 1
Judi Chiao, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Clinical Trial of Oral Administration of the Histone Deacetylase (HDAC) Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) in Patients with Relapsed/Refractory Multiple Myeloma (MM).

Paul Richardson, MD, Robert L. Schlossman, MD, Constantine S. Mitsiades, MD, PhD, Nikhil C. Munshi, MD, Kathleen Colson, Deborah Doss, Mary McKenney, Karen Hande, Svetlana Gorelik, Laura Lunde, Anna Stepanek, Andrea Freeman, Karyn Dinand, Stephen Hayes, Reggie Michelle, Keith Doucet, Diane Warren, Nicholas Mitsiades, MD, PhD, Victoria M. Richon, PhD, Judi Chiao, MD, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2004) 104 (11): 1503.
https://doi.org/10.1182/blood.V104.11.1503.1503
Published: 2004